Why you can trust it.
Every step has been carried out with the people concerned, published and evaluated, through work conducted since 2015 between Geneva and the Caribbean.
First work, with patients: a study of the challenges and opportunities of digital health tools in sickle cell disease, and the co-design of a mobile app and a smartwatch app (Karolinska Institutet, Norwegian Centre for E-health Research, University of Tromsø, HUG and University of Geneva).
DREPACOACH, the first support app designed with patients (HUG, University of Geneva).
Publication of Trévor's design and usefulness study in Frontiers in Digital Health.
“Quality of care” project at HUG, with emergency card, educational content and a link to HUG@Home.
Trévor renewed, evaluated at HUG by the TREVOR-PILOTE study. The haematology teleconsultation and adapted physical activity join Trévor over this period.
The LifeRover study aims to follow families over several years to understand the factors of a better life with sickle cell disease, at school, at work and at home. In Trévor, My life with the illness is its first step.
Contribute, starting today
Ouvrez Trévor: l'utiliser, c'est rejoindre le programme de test (version bêta) et accéder à toutes les fonctions. L'étude clinique TREVOR-PILOTE (huit semaines, aux HUG) ouvrira après l'autorisation de la commission cantonale d'éthique; sa waiting list est déjà ouverte.